- Kindred Biosciences (KIN) submits its marketing application in Europe seeking approval for Mirataz (mirtazapine transdermal gel) for the management of weight loss in cats.
- Separately, the company announces the execution of national distribution agreements with MWI Veterinary Supply Co. and Vets First Choice, both aimed at supplementing Kindred's sales force.
Kindred Bio files Mirataz marketing application in Europe
Recommended For You
More Trending News
About ELAN Stock
Related Stocks
Symbol | Last Price | % Chg |
---|---|---|
ELAN | - | - |
Elanco Animal Health Incorporated |